Madrigal
Madrigal is a biopharmaceutical company developing Rezdiffra (resmetirom), the first U.S. FDA-approved treatment for metabolic dysfunction-associated steatohepatitis (MASH).
0 jobs
Jobs
No jobs match — try clearing a filter.
Madrigal is a biopharmaceutical company developing Rezdiffra (resmetirom), the first U.S. FDA-approved treatment for metabolic dysfunction-associated steatohepatitis (MASH).
0 jobs